SteadyMed Ltd (STDY1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jonathan M. N. Rigby
Employees:
25
5 OPPENHEIMER STREET, REHOVOT, ISRAEL 76701
(925) 272-4991

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

SteadyMed Ltd. engages in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio includes Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and is headquartered in Rehovot, Israel.

Data derived from most recent annual or quarterly report
Market Cap 126.36 Million Shares Outstanding26.743 Million Avg 30-day Volume 85.138 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue279.217 Debt to Equity0.0 EBITDA-16.211 Million
Price to Book Value27.87 Operating Margin-5409.5128 Enterprise Value99.214 Million
Current Ratio4.798 EPS Growth0 Quick Ratio4.798
1 Yr BETA 0.168 52-week High/Low 0.0 / Profit Margin-3926.9142
Operating Cash Flow Growth14.2344 Altman Z-Score-4.8848 Free Cash Flow to Firm -23.253 Million
View SEC Filings from STDY1 instead.

View recent insider trading info

Funds Holding STDY1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding STDY1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STARK BRIAN JAY

  • Director
  • 10% Owner
0 2018-08-30 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED ADVISORS ISRAEL II LTD

ORBIMED ISRAEL GP II, L.P.

  • 10% Owner
No longer subject to file 2018-08-30 0

FARR STEPHEN J

  • Director
0 2018-08-30 0

RIGBY JONATHAN PRESIDENT AND CEO

  • Officer
  • Director
0 2018-08-30 0

CERMAK ELIZABETH

  • Director
0 2018-08-30 0

HUFFMAN DONALD D

  • Director
0 2018-08-30 0

NASSIF DAVID W. EVP AND CFO

  • Officer
0 2018-08-30 0

STEADYMED INVESTORS, LLC

  • 10% Owner
0 2018-08-30 0

BANK KEITH

  • Director
  • 10% Owner
0 2018-08-30 0

GINOR RON

  • Director
0 2018-08-30 0

UNITED THERAPEUTICS CORP

  • 10% Owner
0 2018-04-29 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VI LLC

ORBIMED ADVISORS ISRAEL II LTD

ORBIMED ISRAEL GP II, L.P.

ISALY SAMUEL D

  • 10% Owner
4,539,696 2017-04-25 0

NOYMER PETER D. EVP AND COO

  • Officer
0 2016-11-21 0

FLYNN JAMES E

DEERFIELD MGMT L.P.

DEERFIELD MANAGEMENT CO

DEERFIELD SPECIAL SITUATIONS FUND, L.P.

DEERFIELD MGMT III, L.P.

DEERFIELD PRIVATE DESIGN FUND III, L.P.

  • 10% Owner
  • POSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUPPOSSIBLE MEMBER OF 10% GROUP
No longer subject to file 2015-03-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments